MIDAS ViewPlus Delivers Insight Via Intranet Technology
LONDON, Oct. 14 /PRNewswire/ -- IMS HEALTH (NYSE: RX) has launched a new
information management tool to deliver comprehensive business intelligence to
the desktops of senior pharmaceutical executives via a company's Intranet
system. Combining IMS HEALTH's pharmaceutical market information with the
power of Web-based technology, the new service -- called MIDAS(TM) ViewPlus --
enables decision-makers to filter through the massive amount of data available
to them as they develop business strategies. IMS HEALTH is the world's
leading provider of information solutions to the pharmaceutical and healthcare
industries.
An answer to the age-old challenge of "information overload," MIDAS
ViewPlus organizes the extensive insight available from IMS HEALTH's global
MIDAS(TM) database into a flexible, easy-to-use analytical tool. MIDAS
captures pharmaceutical, chemical and healthcare activity from 76 countries,
ranging from pharmacy and hospital purchases, to prescriber protocols, to
advertising and sales force expenditures for product promotions.
"Integrated into a company's own Intranet, MIDAS ViewPlus delivers an
in-depth overview of global pharmaceutical marketplace trends right to senior
executives' fingertips, and provides updates on key products and late-breaking
news," said Hilary Worton, Senior Consultant, IMS HEALTH Global Services.
"Because it is Intranet-based, MIDAS ViewPlus enables senior managers to share
mission-critical information throughout their organizations quickly and
efficiently, enabling faster business decisions based on important market
trends."
Customized for organizations that subscribe to the service, MIDAS ViewPlus
combines information, decision and process support tools into one
user-friendly application. Among the insights tracked by MIDAS ViewPlus:
pharmaceutical sales and growth trends, the top-20 pharmaceutical products,
the fastest-growing products, leading therapy areas and competitors' market
performance. Sales and growth trends can be "drilled down" to the country,
region, company, therapy class and product level.
In addition to fast insight into the global marketplace, MIDAS ViewPlus
gives pharmaceutical executives a direct line into the local markets where
they need to stay on top of emerging trends. The new information tool offers
support for executive briefings, competitor analyses, portfolio management,
product launches and strategic alliances. Two pharmaceutical giants --
Parke-Davis and Pfizer -- are using MIDAS ViewPlus to help access critical
market information as they co-promote Lipitor, a new cholesterol reducer.
IMS HEALTH
IMS HEALTH is the world's leading provider of information solutions to the
pharmaceutical and healthcare industries. With more than $1 billion in 1997
revenue, IMS HEALTH operates in over 90 countries. IMS HEALTH is the largest
pharmaceutical manufacturer information partner, with over 40 years'
experience in the industry. Key products and services integral to customer
day-to-day operations include: market research for prescription and
over-the-counter pharmaceutical products; sales management information to
optimize sales force productivity; technology enabled selling solutions for
sales and marketing decision-making; technologies systems and information
services that support managed care organizations.
Additional information and previous press releases are available at IMS
HEALTH's web site: http://www.imshealth.com.
SOURCE IMS HEALTH
 back to top
Related links:
http://www.imshealth.com
Company News On-Call:
http://www.prnewswire.com/comp/115785.html or fax,
800-758-5804, ext. 115785
CONTACT:
Michael Gury of IMS HEALTH, 44-171-393-5864
|
